David P. Southwell, Director at PTC THERAPEUTICS, INC. (PTCT), sold 2,317 shares at $30.54 ($72K) on 2014-03-21, disclosed to the SEC on 2014-03-24.
Scheduled sale ($72k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.54 | 1,200 | $37K | 51.1% |
| 2 | $31.35 | 1,117 | $35K | 48.9% |
| Total | $30.93 avg | 2,317 | $72K | 100% |
| Filing → |
| PTCT | SELL | 2023-04-19 | $1.2M | — | Filing → |
| PTCT | SELL | 2023-04-04 | $257K | — | Filing → |
| PTCT | SELL | 2023-03-29 | $897K | — | Filing → |